(Q28254647)

title

MicroRNAs in B-cell lymphomas: how a complex biology gets more complex (English)

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541152%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

K Musilova

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541152%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

English

0 references

publication date

May 2015

0 references

published in

Leukemia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541152%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541152%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541152%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

1004-1017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541152%20AND%20SRC:MED&resulttype=core&format=json

MicroRNAs: target recognition and regulatory functions

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

The impact of microRNAs on protein output

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Most mammalian mRNAs are conserved targets of microRNAs

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

A microRNA expression signature of human solid tumors defines cancer gene targets

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

A microRNA polycistron as a potential human oncogene

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Requirement of bic/microRNA-155 for normal immune function

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

miR-181b negatively regulates activation-induced cytidine deaminase in B cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Identification of tissue-specific microRNAs from mouse

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Identification of novel genes coding for small expressed RNAs

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

MiR-15a and miR-16-1 cluster functions in human leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

mir-29 regulates Mcl-1 protein expression and apoptosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

A microRNA component of the p53 tumour suppressor network

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

c-Myc-regulated microRNAs modulate E2F1 expression

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

miR-19 is a key oncogenic component of mir-17-92

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

miR-34a repression of SIRT1 regulates apoptosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2014.351

Regulation of the germinal center response by microRNA-155

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Treatment of HCV infection by targeting microRNA

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MicroRNAs and hematopoietic cell development

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Roles for microRNAs in conferring robustness to biological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

The hunting of targets: challenge in miRNA research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MicroRNAs prevent the generation of autoreactive antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

The RNase III enzyme Dicer is essential for germinal center B-cell formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

mir-17-92: a polycistronic oncomir with pleiotropic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Identification of an NF-κB p50/p65-responsive site in the human MIR155HG promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

miR-155 regulates HGAL expression and increases lymphoma cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

miR-155: an ancient regulator of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

B-cell activation induced microRNA-21 is elevated in circulating B cells preceding the diagnosis of AIDS-related non-Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

BLIMP-1 and STAT3 counterregulate microRNA-21 during plasma cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Myc overexpression brings out unexpected antiapoptotic effects of miR-34a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

c-Myb is critical for B cell development and maintenance of follicular B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

The role of microRNA-150 as a tumor suppressor in malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Therapeutic targeting of microRNAs: current status and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

miR-34 - a microRNA replacement therapy is headed to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Mantle cell lymphoma: transcriptional regulation by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.351

Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy

21 January 2018

1 reference

12 December 2020

MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas

1 reference

12 December 2020

Missense mutations located in structural p53 DNA-binding motifs are associated with extremely poor survival in chronic lymphocytic leukemia

1 reference

12 December 2020

miR-34a as part of the resistance network in chronic lymphocytic leukemia

1 reference

12 December 2020

Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines

1 reference

12 December 2020

The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation

1 reference

12 December 2020

B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells

1 reference

12 December 2020

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia

1 reference

12 December 2020

LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2014.351

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541152%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 June 2020

1052226500

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541152%20AND%20SRC:MED&resulttype=core&format=json